Toxicological Screening of 4‑Phenyl-3,4-dihydrobenzo[h]quinolin-2(1H)‑one: A New Potential Candidate for Alzheimer’s Treatment

• Fareeha Anwar,
• Uzma Saleem,
• Atta ur Rehman,
• Bashir Ahmad,
• Tariq Ismail,
• Muhammad Usman Mirza,
• Lee Yean Kee,
• Iskandar Abdullah,
• Sarfraz Ahmad

Affiliations

Fareeha Anwar

Riphah Institute of Pharmaceutical Sciences, Riphah International University, Lahore, Pakistan

Uzma Saleem

Department of Pharmacology, Faculty of Pharmaceutical Sciences, Govt. College University, Faisalabad, Pakistan

Atta ur Rehman

Department of Pharmacy, Forman Christian College, Lahore, Pakistan

Bashir Ahmad

Riphah Institute of Pharmaceutical Sciences, Riphah International University, Lahore, Pakistan

Tariq Ismail

Department of Pharmacy, COMSATS Institute of Information Technology, Abottabad, Pakistan

Muhammad Usman Mirza

Department of Pharmaceutical and Pharmacological Sciences, Rega Institute for Medical Research, Medicinal Chemistry, University of Leuven, Leuven, Belgium

Lee Yean Kee

Drug Design and Development Research Group (DDDRG), Department of Chemistry, Faculty of Science, Universiti Malaya, Kuala Lumpur, Malaysia

Iskandar Abdullah

Drug Design and Development Research Group (DDDRG), Department of Chemistry, Faculty of Science, Universiti Malaya, Kuala Lumpur, Malaysia

Sarfraz Ahmad

Drug Design and Development Research Group (DDDRG), Department of Chemistry, Faculty of Science, Universiti Malaya, Kuala Lumpur, Malaysia